1. Home
  2. INKT vs RDI Comparison

INKT vs RDI Comparison

Compare INKT & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • RDI
  • Stock Information
  • Founded
  • INKT 2017
  • RDI 1937
  • Country
  • INKT United States
  • RDI United States
  • Employees
  • INKT N/A
  • RDI N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • RDI Movies/Entertainment
  • Sector
  • INKT Health Care
  • RDI Consumer Discretionary
  • Exchange
  • INKT Nasdaq
  • RDI Nasdaq
  • Market Cap
  • INKT 33.6M
  • RDI 30.1M
  • IPO Year
  • INKT 2021
  • RDI N/A
  • Fundamental
  • Price
  • INKT $9.03
  • RDI $1.25
  • Analyst Decision
  • INKT Strong Buy
  • RDI Hold
  • Analyst Count
  • INKT 2
  • RDI 1
  • Target Price
  • INKT $37.50
  • RDI $2.40
  • AVG Volume (30 Days)
  • INKT 10.5K
  • RDI 46.6K
  • Earning Date
  • INKT 03-18-2025
  • RDI 05-14-2025
  • Dividend Yield
  • INKT N/A
  • RDI N/A
  • EPS Growth
  • INKT N/A
  • RDI N/A
  • EPS
  • INKT N/A
  • RDI N/A
  • Revenue
  • INKT N/A
  • RDI $197,270,000.00
  • Revenue This Year
  • INKT N/A
  • RDI N/A
  • Revenue Next Year
  • INKT N/A
  • RDI $18.29
  • P/E Ratio
  • INKT N/A
  • RDI N/A
  • Revenue Growth
  • INKT N/A
  • RDI N/A
  • 52 Week Low
  • INKT $4.56
  • RDI $1.22
  • 52 Week High
  • INKT $19.00
  • RDI $1.90
  • Technical
  • Relative Strength Index (RSI)
  • INKT 53.66
  • RDI 36.22
  • Support Level
  • INKT $7.81
  • RDI $1.27
  • Resistance Level
  • INKT $9.23
  • RDI $1.46
  • Average True Range (ATR)
  • INKT 0.85
  • RDI 0.10
  • MACD
  • INKT 0.11
  • RDI -0.00
  • Stochastic Oscillator
  • INKT 68.66
  • RDI 5.71

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.

Share on Social Networks: